AstraZeneca PLC
10 September 2007
Publication of Prospectus
AstraZeneca PLC has published a prospectus dated 10 September 2007 in respect of
its US$5,000,000,000 Euro Medium Term Note Programme.
To view the full prospectus, please paste the URL below into the address bar of
your browser.
http://www.rns-pdf.londonstockexchange.com/rns/6264d_-2007-9-10.pdf
One of the documents incorporated by reference into the prospectus has not
previously been published by AstraZeneca PLC; in order to view this document,
please paste the URL below into the address bar of your browser.
http://www.sec.gov/Archives/edgar/data/873591/000110465907014449/a07-5178_310k.htm
G H R Musker
Company Secretary
10 September 2007
Please note that the prospectus contains restrictions on the sale of the
securities described therein to persons in certain jurisdictions and that the
prospectus is not addressed to such persons, nor should such persons use or rely
on the information contained therein.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.